• EN

Published: 15 November 2011

Figure 17: Prevalence of HCV antibodies among injecting drug users

Annual report figure


Data for the years 2008 and 2009. Black squares are samples with national coverage; blue triangles are samples with sub-national (local or regional) coverage. Differences between countries have to be interpreted with caution owing to differences in types of settings and study methods; national sampling strategies vary. Countries are presented by order of increasing prevalence, based on the average of national data or, if not available, of sub-national data. For more information, see Figure INF-6 in the 2011 statistical bulletin.


Reitox national focal points.

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Tel. (351) 211 21 02 00

More contact options >>

Page last updated: Friday, 28 October 2011